Development Level

Tchem 3 | 1,890
Tbio 1 | 10,625
Tclin 1 | 602

Disease

Arthritis 3 | 248
Cancer 3 | 2,346
diabetes mellitus 3 | 1,663
osteosarcoma 3 | 7,933
periodontitis 3 | 269
psoriasis 3 | 6,685
tuberculosis 3 | 1,557
ulcerative colitis 3 | 2,087
Allergic hypersensitivity disease 2 | 123
Alzheimer's disease 2 | 644
Asthma 2 | 349
Autistic Disorder 2 | 320
Chronic obstructive pulmonary disease 2 | 146
Dermatitis 2 | 107
Hepatitis C 2 | 90
Inflammatory bowel disease 2 | 142
Irritable bowel syndrome 2 | 59
Migraine 2 | 79
Neuropathy 2 | 210
Obesity 2 | 616
Parkinson's disease 2 | 364
Schizophrenia 2 | 501
Vascular disease 2 | 281
lung cancer 2 | 4,466
ovarian cancer 2 | 8,484
pancreatic cancer 2 | 2,300
pituitary cancer 2 | 1,972
Adult T-Cell Lymphoma/Leukemia 1 | 30
Advanced sleep phase syndrome 1 | 10
Alcohol dependence 1 | 107
Anxiety Disorders 1 | 37
Anxiety disorder 1 | 22
Appendicitis 1 | 18
Arthritis, Experimental 1 | 39
Arthropathy 1 | 34
Aspergillosis 1 | 23
Behcet Syndrome 1 | 23
Candidiasis 1 | 48
Chlamydia 1 | 18
Common cold 1 | 63
Complex regional pain syndrome 1 | 12
Dengue disease 1 | 19
Depersonalization disorder 1 | 4
Diabetes Mellitus, Insulin-Dependent 1 | 76
Diarrhea 1 | 155
Eating disorder 1 | 24
Echinococcosis 1 | 28
Ehrlichiosis 1 | 9
Epicondylitis 1 | 19
Fibromyalgia 1 | 22
Filariasis 1 | 21
Gastritis 1 | 44
Glomerulonephritis 1 | 36
HIV Infections 1 | 100
Hepatolenticular Degeneration 1 | 24
Human immunodeficiency virus infectious disease 1 | 92
Hyperactive behavior 1 | 31
Hypercalcemia 1 | 37
Hyperglycemia 1 | 120
Hyperparathyroidism 1 | 43
Immediate hypersensitivity 1 | 8
Infantile malignant osteopetrosis 1 | 4
Keratoconjunctivitis sicca 1 | 19
Leishmaniasis, Visceral 1 | 13
Leprosy 1 | 77
Liver Cirrhosis, Experimental 1 | 108
Liver disease 1 | 219
Lupus Erythematosus, Systemic 1 | 73
Lyme disease 1 | 23
Mammary Neoplasms, Experimental 1 | 150
Mastitis 1 | 48
Meningitis 1 | 46
Multiple personality disorder 1 | 8
Myocardial Infarction 1 | 126
Narcolepsy 1 | 58
Osteopetrosis 1 | 40
Paget's disease of bone 1 | 28
Pancreatitis 1 | 97
Primary immunodeficiency disease 1 | 52
Prostatitis 1 | 15
Psoriatic arthritis 1 | 83
Q fever 1 | 11
Respiratory failure 1 | 30
Rhinitis 1 | 46
Root resorption 1 | 21
Rosacea 1 | 18
Schistosomiasis 1 | 38
Sepsis 1 | 21
Squamous cell carcinoma of esophagus 1 | 82
Sudden infant death syndrome 1 | 33
Synovitis 1 | 38
Tetanus 1 | 66
Toxic shock syndrome 1 | 28
Toxoplasmosis 1 | 16
Type 1 diabetes mellitus 1 | 101
Uveitis 1 | 103
Weight decreased 1 | 18
Withdrawal disorder 1 | 19
chronic kidney disease 1 | 90
interstitial lung disease 1 | 291

Tissue

Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Nervous System 5 | 18,561
Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Non-IDG 4 | 11,971
Enzyme 1 | 4,146

Grant Application

1K22DE014551-01 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Marginal zone B- and B1-cell-specific protein MZB1 Tbio Non-IDG -0.97428 13.9 63
Tumor necrosis factor ligand superfamily member 11 TNFSF11 Tclin Non-IDG -3.51869 3934.6 609
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Interleukin-10 IL10 Tchem Non-IDG -4.03858 11514.6 1151
Pituitary adenylate cyclase-activating polypeptide ADCYAP1 Tchem Enzyme -3.02985 1222.0 164